1. A Review of Methods Used in Long-Term Cost-Effectiveness Models of Diabetes Mellitus Treatment

   • Jean-Eric Tarride
   • Robert Hopkins
   • Ron Goeree

   Review Article 29 September 2012 Pages: 255 - 277

   

2. Cost Effectiveness of Respiratory Syncytial Virus Prophylaxis

   • William A. Prescott Jr
   • Fred Doloresco
   • Joseph A. Paladino

   Review Article 29 September 2012 Pages: 279 - 293

   

3. Does the Funding Source Influence the Results in Economic Evaluations?

   • Rachael L. Fleurence
   • D. Eldon Spackman
   • Christopher Hollenbeak

   Original Research Article 29 September 2012 Pages: 295 - 306

   

4. Pharmacoeconomic Evaluation in Ireland

   • Lesley Tilson
   • Aisling O’Leary
   • Michael Barry

   Original Research Article 29 September 2012 Pages: 307 - 322

   

5. Cost Effectiveness of Etoricoxib versus Celecoxib and Non-Selective NSAIDS in the Treatment of Ankylosing Spondylitis

   • Jeroen P. Jansen
   • Sabine Gaugris
   • Wiro Stam

   Original Research Article 29 September 2012 Pages: 323 - 344

   

6. Towards More Consistent Use of Generic Quality-of-Life Instruments

   • Mattias Neyt

   Correspondence 29 September 2012 Pages: 345 - 346